Condom shelf-life testing on first three lots, in lieu of "random" testing, supported by HIMA.
This article was originally published in The Tan Sheet
Executive Summary
LATEX CONDOM SHELF-LIFE TESTING ON INITIAL THREE LOTS should be adequate for FDA in lieu of testing on three "discrete and random lots" as proposed by the agency, the Health Industry Manufacturers Association said in Aug. 22 comments on FDA's May 24 proposed regs for condom labeling. The proposal would allow latex condom expiration dating of up to five years based on short-term accelerated aging studies and follow-up real-time testing ("The Tan Sheet" May 27, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning